 1.  Short title This Act may be cited as the  LymeX Authorization Act . 
 2.  Policy  It is the policy of the United States toâ€”  (1)  engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care;  (2)  foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and  (3)  accelerate development of next-gen diagnostics that are rapid and patient focused. 
 3.  Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3719 )) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.
